Search

Your search keyword '"Hugosson, Jonas"' showing total 432 results

Search Constraints

Start Over You searched for: Author "Hugosson, Jonas" Remove constraint Author: "Hugosson, Jonas" Language english Remove constraint Language: english
432 results on '"Hugosson, Jonas"'

Search Results

Catalog

Books, media, physical & digital resources

6. Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative

8. Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium

9. Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database

11. The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer

13. Results after Four Years of Screening for Prostate Cancer with PSA and MRI.

15. Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance Initiative

17. Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts

18. A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

22. Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium

30. Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts

31. Survivorship Data in Prostate Cancer: Where Are We and Where Do We Need To Be?

38. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

40. Prostate cancer: ESMO Consensus Conference Guidelines 2012

50. Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)